Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXTOR-HF: Extended Release vs Immediate Release Torsemide in Heart Failure
NCT06708611Phase 4Withdrawn
- Start
- Jan 2025
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of torasemide in heart failure (HF). Planned start Jan 2025; status: withdrawn.
02
Drugs
torasemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06708611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06708611.